KUALA LUMPUR, April 14 — Individuals aged 60 and above with high-risk comorbidities are now given the option of getting a second booster dose of the vaccine, with an interval of at least four to six months after the date of the first booster dose.
Health Minister Khairy Jamaluddin said the decision was made after a scientific study and a Malaysian cohort study by the Technical Working Group (TWG) panel, which found that individuals aged 60 and above with higher-risk comorbidities had serious symptoms and death due to COVID-19.
“Currently, the Comirnaty mRNA vaccine (Pfizer-BioNTech) is the recommended vaccine for a second booster dose, based on available scientific data,” he told a press conference in Parliament building here today.
Khairy said for individuals aged 60 and above who have received a booster dose and tested positive for COVID-19, they were eligible to receive a second booster dose three months after they fully recovered.
For individuals aged 60 and above who are healthy and do not have high-risk comorbidities, he said they should talk to a medical practitioner about whether a second booster dose would be recommended for them.
